MMP-9, a matrix metalloproteinase involved in extracellular matrix remodeling, is closely associated with fibrosis, and its elevated levels, along with the concurrent rise in CLU, suggest that fibrotic changes contribute significantly to kidney damage at this stage. Here, MMP9 is linked to Nephropathy.